These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10476855)

  • 1. A short and efficient synthesis of 4-[2,2-dimethyl-4(tol-4-yl)benzochrom-3-en-7-yl]benzoic acid - a potent retinoic acid receptor antagonist.
    Vuligonda V; Chandraratna RA
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2289-90. PubMed ID: 10476855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and evaluation of naphthalenyl- and chromenyl-pyrrolyl-benzoic acids as potent and selective retinoic acid receptor alpha agonists.
    Hibi S; Tagami K; Kikuchi K; Yoshimura H; Tai K; Hida T; Tokuhara N; Yamauchi T; Nagai M
    Bioorg Med Chem Lett; 2000 Apr; 10(7):623-5. PubMed ID: 10762039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical synthesis of a chromene analog for use as a retinoic acid receptor alpha antagonist lead compound.
    Jetson R; Malik N; Luniwal A; Chari V; Ratnam M; Erhardt P
    Eur J Med Chem; 2013 May; 63():104-8. PubMed ID: 23474897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid X receptor-antagonistic diazepinylbenzoic acids.
    Ebisawa M; Umemiya H; Ohta K; Fukasawa H; Kawachi E; Christoffel G; Gronemeyer H; Tsuji M; Hashimoto Y; Shudo K; Kagechika H
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1778-86. PubMed ID: 10748721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
    Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
    Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.
    Álvarez S; Lieb M; Martínez C; Khanwalkar H; Rodríguez-Barrios F; Álvarez R; Gronemeyer H; de Lera AR
    ChemMedChem; 2015 Aug; 10(8):1378-91. PubMed ID: 26012882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel type of retinoic acid receptor antagonist: synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives.
    Yoshimura H; Nagai M; Hibi S; Kikuchi K; Abe S; Hida T; Higashi S; Hishinuma I; Yamanaka T
    J Med Chem; 1995 Aug; 38(16):3163-73. PubMed ID: 7636879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of highly potent retinoic acid receptor alpha-selective antagonists.
    Teng M; Duong TT; Johnson AT; Klein ES; Wang L; Khalifa B; Chandraratna RA
    J Med Chem; 1997 Aug; 40(16):2445-51. PubMed ID: 9258350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity.
    Kikuchi K; Hibi S; Yoshimura H; Tokuhara N; Tai K; Hida T; Yamauchi T; Nagai M
    J Med Chem; 2000 Feb; 43(3):409-19. PubMed ID: 10669568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and evaluation of quinoline derivatives as novel retinoic acid receptor alpha antagonists.
    Kikuchi K; Tagami K; Hibi S; Yoshimura H; Tokuhara N; Tai K; Hida T; Yamauchi T; Nagai M
    Bioorg Med Chem Lett; 2001 May; 11(9):1215-8. PubMed ID: 11354380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
    Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
    J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
    Schupp M; Curtin JC; Kim RJ; Billin AN; Lazar MA
    Mol Pharmacol; 2007 May; 71(5):1251-7. PubMed ID: 17290005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antagonist of retinoid toxicity in mice.
    Standeven AM; Johnson AT; Escobar M; Chandraratna RA
    Toxicol Appl Pharmacol; 1996 May; 138(1):169-75. PubMed ID: 8658506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of retinoic acid-receptor-independent retinoid X-receptor-dependent pathway in myeloid cell function.
    Hida T; Tai K; Tokuhara N; Ishibashi A; Kikuchi K; Hibi S; Yoshimura H; Nagai M; Yamauchi T; Kobayashi S
    Jpn J Pharmacol; 2001 Jan; 85(1):60-9. PubMed ID: 11243576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a retinoid receptor antagonist in a new model to study vitamin A-dependent developmental events.
    Kochhar DM; Jiang H; Penner JD; Johnson AT; Chandraratna RA
    Int J Dev Biol; 1998 May; 42(4):601-8. PubMed ID: 9694631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
    Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
    Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the differential coregulator binding signatures of the Retinoic Acid Receptor subtypes upon (ant)agonist action.
    Miro Estruch I; Melchers D; Houtman R; de Haan LHJ; Groten JP; Louisse J; Rietjens IMCM
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1195-1206. PubMed ID: 28642153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity.
    Beard RL; Klein ES; Standeven AM; Escobar M; Chandraratna RA
    Bioorg Med Chem Lett; 2001 Mar; 11(6):765-8. PubMed ID: 11277515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
    Kooistra T; Lansink M; Arts J; Sitter T; Toet K
    Eur J Biochem; 1995 Sep; 232(2):425-32. PubMed ID: 7556191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of RXR antagonists based on the diazepinylbenzoic acid structure.
    Sakaki J; Konishi K; Kishida M; Gunji H; Kanazawa T; Uchiyama H; Fukaya H; Mitani H; Kimura M
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4808-11. PubMed ID: 17651969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.